Blood pressure and fluid retention drugs recalled over cancer concerns

The FDA has published a new recall advisory from Lupin Pharmaceuticals over two different drugs: Hydrochlorothiazide and Irbesartan. The company, which stopped marketing these particular drugs in January, says it is recalling the batches due to potentially higher than acceptable levels of an impurity called N-nitrosoirbesartan. The recall covers the pharmaceutical company’s Irbesartan Tablets USP in 75mg, 150mg, and 300mg …